Lexaria Bioscience Corp. (LEXX) quarterly cash flow statement — complete operating, investing & financing history
Lexaria Bioscience Corp. (LEXX) cash flow statement — 20-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -1.64M | -2.16M | -984.1K | -2.64M | -3.58M | -1.5M | -2.73M | -1.89M | -1.27M | -619.61K | -1.18M | -1.62M | -1.79M | -1.23M | -1.25M | -1.18M | -1.26M | -1.28M | -1.17M | -1.08M |
| Operating CF Margin % | - | -10819.36% | - | -1518.68% | -2059.74% | -860.86% | -1482.17% | -2251.97% | -1507.23% | -427.32% | -781.11% | 47237.98% | -2298.33% | -6133.72% | -1274.17% | -1058.58% | -1262.7% | -4167.28% | -8402.91% | -3479.02% |
| Operating CF Growth % | 54.38% | -44.46% | 63.9% | -39.69% | -183.08% | -141.75% | -130.7% | -16.65% | 29.11% | 49.55% | 5.11% | -37.83% | -41.84% | 3.84% | -6.77% | -9.02% | -8.85% | -40.17% | -44.07% | -58.25% |
| Net Income | -1.99M | -1.45M | -1.6M | -2.7M | -3.79M | -2.72M | -2.71M | -2.19M | -1.78M | -652.73K | -1.19M | -1.25M | -2.38M | -1.31M | -1.77M | -1.51M | -2.42M | -1.45M | -2M | -1.32M |
| Depreciation & Amortization | 19.21K | 19.1K | 16.87K | 21.4K | 30.95K | 2.28K | 33.2K | -7.76K | 15.07K | 15.93K | 28.78K | 70.93K | 25.01K | 24.73K | 24.73K | 63.33K | 23.89K | 26.16K | 27.93K | 63.81K |
| Stock-Based Compensation | 92.94K | 74.89K | 74.89K | 122.72K | 470.14K | 167.22K | 99.42K | 96.51K | 341.77K | 0 | 53.95K | 9.63K | 81.45K | 10.53K | 68.78K | 232.87K | 111.17K | 0 | 408.54K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 9.27K | 9.27K | 22.02K | 234.54K | 49.64K | 17.85K | 16.12K | 32.03K | 85.06K | 26.54K | 55.2K | 261.63K | 11.1K | 22.14K | 77.37K | 505.12K | 853.39K | 252.11K | 351.25K | 159.19K |
| Working Capital Changes | 236.54K | -814.4K | 499.62K | -323.93K | -344.08K | 1.03M | -168.14K | 174.13K | 76.32K | -9.35K | -134.55K | -714.85K | 480.04K | 24.96K | 353.11K | -464.78K | 170.75K | -106.87K | 49.43K | 22.44K |
| Change in Receivables | -6.97K | 46.02K | 280.31K | -10.23K | -26.96K | -67.67K | -109.45K | 46.21K | 124.56K | 186.71K | -408.05K | -2.96K | -35.49K | 149.53K | -84.54K | -46.92K | 73.65K | -45.11K | -119.11K | 190.69K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.36K | 2.92K | 30.79K | 7.22K | -8.04K | -4.08K | 2.91K | 23.06K |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -783.65K | 833.81K | -52.12K | 90.44K | -5.63K | 40.48K | -72.95K | 88.82K | -73.18K |
| Cash from Investing | -27.09K | -53.91K | -5.1K | -157.88K | -19.44K | -27.89K | -37.8K | -69.59K | -22K | -56.99K | -40.03K | -68.44K | -33.65K | -32.68K | -34.84K | -50.05K | -37.96K | -34.42K | -58.22K | -2 |
| Capital Expenditures | -26.25K | -40.82K | -5.1K | -1 | 1 | -1 | -24.64K | -43.01K | -22K | -56.99K | -40.03K | -68.44K | -33.65K | -13.25K | -20.5K | -50.04K | -6.81K | -34.42K | -42.38K | 0 |
| CapEx % of Revenue | - | 204.08% | - | 0% | 0% | 0% | 13.4% | 51.21% | 26.19% | 39.3% | 26.46% | -1993.5% | 43.3% | 66.16% | 20.98% | 45.02% | 6.83% | 112.31% | 305.3% | 0.01% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -837 | -13.09K | 0 | -157.88K | -19.44K | -27.89K | -13.16K | -26.57K | 0 | 0 | 0 | 0 | 0 | -19.44K | -14.34K | -4 | -31.14K | 0 | -15.84K | 0 |
| Cash from Financing | 0 | 3.04M | 3.47M | 0 | 1.69M | 11.72K | 4.35M | 0 | 5.04M | 3.45M | 1.82M | -121.69K | 1.71M | 0 | 0 | -11.21K | -11.2K | -11.2K | -10.99K | 3.97M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.2K | -11.2K | -11.21K | -11.2K | -11.2K | -10.99K | 419 |
| Equity Issued (Net) | 0 | 3.04M | 3.47M | 0 | 1.69M | 11.72K | 4.35M | 0 | 0 | 2.96M | 1.25M | -121.69K | 1.71M | 0 | 0 | 0 | 0 | 0 | 0 | 4.02M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.04M | 491.82K | 571.65K | 0 | 0 | -11.2K | 11.2K | 0 | 0 | 0 | 0 | -43.95K |
| Net Change in Cash | -1.65M | 846.91K | 2.48M | -2.79M | -1.88M | -1.61M | 1.58M | -1.96M | 3.75M | 2.75M | 602.06K | -1.81M | -108.2K | -1.26M | -1.28M | -1.24M | -1.31M | -1.32M | -1.24M | 2.81M |
| Free Cash Flow | -1.66M | -2.22M | -989.2K | -2.66M | -3.6M | -1.53M | -2.76M | -1.96M | -1.29M | -676.6K | -1.22M | -1.69M | -1.82M | -1.26M | -1.28M | -1.23M | -1.3M | -1.31M | -1.22M | -1.08M |
| FCF Margin % | - | -11098.91% | - | -1527.07% | -2070.92% | -876.89% | -1502.72% | -2334.82% | -1533.43% | -466.62% | -807.57% | 49231.49% | -2341.63% | -6296.93% | -1309.82% | -1103.6% | -1300.77% | -4279.59% | -8822.33% | -3479.03% |
| FCF Growth % | 53.9% | -45.48% | 64.21% | -35.48% | -179.75% | -125.51% | -126.23% | -16.04% | 29.21% | 46.34% | 4.57% | -37.78% | -40.28% | 3.87% | -4.54% | -13.66% | -5.67% | -43.47% | -50.19% | -55.15% |
| FCF per Share | -1.00 | -1.36 | -0.69 | -2.04 | -2.95 | -1.31 | -2.49 | -2.24 | -1.39 | -0.94 | -0.13 | -0.26 | -0.28 | -0.21 | -0.22 | -0.21 | -0.22 | -0.22 | -0.21 | -0.21 |
| FCF Conversion (FCF/Net Income) | 0.82x | 1.49x | 0.62x | 0.98x | 0.95x | 0.55x | 1.01x | 0.87x | 0.71x | 0.95x | 1.00x | 1.31x | 0.75x | 0.95x | 0.71x | 0.80x | 0.53x | 0.90x | 0.59x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 14 | 2.6K | 0 | 0 | 0 | 0 | 0 | -3.66K | 0 | 0 | 3.66K | 0 | 0 | 0 | 0 | 4.78K | 0 | 0 | 0 | 12.76K |